Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.58ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.58ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.58EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.58EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.487EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.487EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.487ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.487ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.487EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.487EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.487ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.487ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.68EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.68ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.68ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.68EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.68EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.68ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.121EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.121EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.121ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.121ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.121EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.121EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.121ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.121ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AA.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AA.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AA.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AA.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AS.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AS.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AS.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AS.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AS.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AS.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AS.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used